Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
An increase in blood glucose during antihypertensive treatment is an
independent risk factor for myocardial infarction. Dunder and
colleagues (p 681) studied a cohort of 1860 Swedish men who had
participated in a baseline investigation when aged 50 and who were
re-examined at age 60. A significant interaction existed between
proinsulin concentration at baseline and antihypertensive treatment on
increase in blood glucose, suggesting that the metabolic impact of
antihypertensives increases the risk of myocardial infarction in an
insulin resistant state.